Literature DB >> 1324943

Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.

B A Lee1, D J Donoghue.   

Abstract

An important question regarding autocrine transformation by v-sis is whether intracellularly activated PDGF receptors are sufficient to transform cells or whether activated receptor-ligand complexes are required at the cell surface. We have addressed this question by inhibiting cell surface transport of a membrane-anchored v-sis protein utilizing the ER retention signal of the adenoviral transmembrane protein E3/19K. A v-sis fusion protein containing this signal was retained within the cell and not transported to the cell surface as confirmed by immunofluorescent localization experiments. Also, proteolytic maturation of this protein was suppressed, indicating inefficient transport to post-Golgi compartments of the secretory pathway. When compared with v-sis proteins lacking a functional retention signal, the ER-retained protein showed a diminished ability to transform NIH 3T3 cells, as measured by the number and size of foci formed. In newly established cell lines, the ER-retained protein did not down-regulate PDGF receptors. However, continued passage of these cells selected for a fully transformed phenotype exhibiting downregulated PDGF receptors and proteolytically processed v-sis protein. These results indicate that productive autocrine interactions occur in a post-ER compartment of the secretory pathway. Transport of v-sis protein beyond the Golgi correlated with acquisition of the transformed phenotype. Furthermore, suramin treatment reversed transformation and upregulated the expression of cell surface PDGF receptors, suggesting an important role for receptor-ligand complexes localized to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324943      PMCID: PMC2289590          DOI: 10.1083/jcb.118.5.1057

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

1.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Authors:  T P Fleming; T Matsui; C J Molloy; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Transformation by v-sis occurs by an internal autoactivation mechanism.

Authors:  B E Bejcek; D Y Li; T F Deuel
Journal:  Science       Date:  1989-09-29       Impact factor: 47.728

3.  Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.

Authors:  M T Keating; L T Williams
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

Review 4.  Perturbation of vesicular traffic with the carboxylic ionophore monensin.

Authors:  A M Tartakoff
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

Review 5.  Suramin: prototype of a new generation of antitumor compounds.

Authors:  R V La Rocca; C A Stein; C E Myers
Journal:  Cancer Cells       Date:  1990-04

6.  Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.

Authors:  V B Lokeshwar; S S Huang; J S Huang
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

Review 7.  Growth factors and cancer.

Authors:  S A Aaronson
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product.

Authors:  C R King; N A Giese; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus.

Authors:  A Johnsson; C Betsholtz; C H Heldin; B Westermark
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

10.  Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.

Authors:  M Hannink; D J Donoghue
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  8 in total

Review 1.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Authors:  B D Galvin; K C Hart; A N Meyer; M K Webster; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 3.  The road less travelled: c-kit and stem cell factor.

Authors:  W Hamel; M Westphal
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

4.  Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Authors:  M K Webster; D J Donoghue
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

5.  Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.

Authors:  S M Shamah; C D Stiles; A Guha
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.

Authors:  K C Hart; Y F Xu; A N Meyer; B A Lee; D J Donoghue
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

7.  Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.

Authors:  L I Chen; M K Webster; A N Meyer; D J Donoghue
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

8.  Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization.

Authors:  H S Wiley; M F Woolf; L K Opresko; P M Burke; B Will; J R Morgan; D A Lauffenburger
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.